Regarding approaches to optimizing IVF-ET outcomes in infertile women with endometriosis, the use of prolonged GnRH agonist treatment (for 3 to 6 months) prior to IVF-ET has been reported to improve the pregnancy rate [21, 22, 28]. The gene discussed is GNRH1; the disease is endometriosis.